Kiniksa Pharmaceuticals International, plc (KNSA)
Market Closed
17 Jul, 20:00
NASDAQ (NGS) NASDAQ (NGS) Primary $
63. 95
+2.84
+4.6474%
$
4.66B Market Cap
84.4 P/E Ratio
- Div Yield
712,400 Volume
-0.16 Eps
$ 61.11
Previous Close 
Want to track KNSA and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Kiniksa Pharmaceuticals International, plc Analysts
| Name | Quantity | Cost | Value | Profit ($) | Gain (%) |
|---|---|---|---|---|---|
| GM Geoff Meacham B of A Securities | 618.51 | $26,734.46 | $38,155.62 | $11,421.16 | 42.72% |
| EFV Eva Fortea Verdejo Wells Fargo | 138.37 | $6,548.39 | $8,859.86 | $2,311.47 | 35.3% |
| RS Roger Song Jefferies | 361.06 | $17,839.2 | $22,273.97 | $4,434.77 | 24.86% |
